07 Jan 2001

Psorcutan® Salbe (Psorcutan® Salbe) - Deutschland

Updated: 07 Jan 2001

Psorcutan® Salbe

Leichte bis mittelschwere Psoriasis vom Plaque Typ.

Psorcutan® Salbe Description, Presentation and Dosage

Psorcutan® Salbe Description

Psorcutan® Salbe Drug Class Description

Einzelstoffe

Psorcutan® Salbe Drug Description

1 g enth.: Calcipotriol 0,05 mg.

Psorcutan® Salbe Generic Name

Psorcutan® Salbe

Psorcutan® Salbe Presentation

Psorcutan® Salbe Presentation

Psorcutan® Salbe

Psorcutan® Salbe Manufacturer

Schering/Asche

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

COPD Knowledge Centre

COPD Knowledge Centre

The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2014 and ATS 2015 are available free of charge.

Psorcutan® Salbe Dosage

Psorcutan® Salbe Adult Dosage

Wasser-Öl-Emulsion, gereinigtes Wasser, Dinatriumedetat 2H2O, Natriummonohydrogenphosphat 2H2O, 'alpha'-Tocopherol, dickflüssiges Paraffin, 'alpha'-Octadecyl-'omega'-hydroxypoly(oxyethylen)-2, Propylenglycol, weißes Vaselin.

Psorcutan® Salbe Precautions, Reactions and Contraindications

Psorcutan® Salbe Special Precautions

Psorcutan® Salbe Special Precautions

Anw. auf größeren Hautflächen als max. 30% d. Körpers. Psoriasis punctata, Psoriasis pustulosa, schwere Nieren- o. Lebererkrank. b. allen Erkrank. die m. Veränd. d. Kalziumstoffwechsels einhergehen, i. Gesicht u. auf d. behaarten Kopf, b. Pers. unter 18 Jahren.

Psorcutan® Salbe Adverse Reactions

Psorcutan® Salbe Adverse Reactions

Kontraind. Gr 4 .

Related Drugs - Dermatology

Back to top